HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Van de Werf Selected Research

Staphylococcus aureus auR protein (staphylokinase)

9/2003Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
10/2000Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
5/2000Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Van de Werf Research Topics

Disease

22Myocardial Infarction
10/2010 - 03/2000
10ST Elevation Myocardial Infarction
01/2010 - 12/2000
9Infarction (Infarctions)
06/2002 - 02/2000
7Acute Coronary Syndrome
02/2007 - 07/2001
3Hemorrhage
12/2001 - 12/2000
2Heart Arrest (Cardiac Arrest)
02/2007 - 03/2000
2Atrial Fibrillation
09/2004 - 12/2001
2Necrosis
09/2002 - 01/2001
2Hyperplasia
10/2001 - 08/2000
2Pathologic Constriction (Stenosis)
10/2001 - 08/2000
2Stroke (Strokes)
12/2000 - 06/2000
2Unstable Angina
06/2000 - 01/2000
1Shock
08/2009
1Congenital Heart Defects (Congenital Heart Defect)
09/2004
1Pulmonary Arterial Hypertension
09/2004
1Atrial Flutter (Flutter, Atrial)
09/2004
1Eisenmenger Complex (Eisenmenger's Syndrome)
09/2004
1Chest Pain (Chest Pains)
09/2003
1Cardiovascular Diseases (Cardiovascular Disease)
01/2003
1Body Weight (Weight, Body)
12/2001
1Myocardial Stunning (Stunned Myocardium)
08/2001
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2001
1Intracranial Hemorrhages (Intracranial Hemorrhage)
05/2001
1Diabetes Mellitus
05/2001
1Pain (Aches)
04/2001
1Cardiac Arrhythmias (Arrythmia)
03/2001
1Thrombosis (Thrombus)
08/2000
1Vascular Diseases (Vascular Disease)
06/2000
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2000
1Transient Ischemic Attack
06/2000
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
06/2000
1Ischemic Stroke
06/2000

Drug/Important Bio-Agent (IBA)

7Tissue Plasminogen Activator (Alteplase)FDA Link
09/2003 - 03/2000
7Heparin (Liquaemin)FDA LinkGeneric
07/2003 - 12/2000
4Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2007 - 06/2001
3Staphylococcus aureus auR protein (staphylokinase)IBA
09/2003 - 05/2000
3TenecteplaseFDA Link
07/2003 - 05/2000
3Abciximab (ReoPro)FDA Link
06/2002 - 06/2000
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2001 - 06/2000
2FibrinIBA
12/2007 - 12/2001
2MB Form Creatine KinaseIBA
02/2006 - 02/2004
2paragonIBA
07/2005 - 07/2001
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
07/2003 - 01/2000
2HirudinsIBA
08/2002 - 12/2001
2reteplaseFDA Link
06/2002 - 12/2000
2Factor Xa (Coagulation Factor Xa)IBA
09/2001 - 08/2001
1Valsartan (Vals)FDA Link
10/2010
1Blood Glucose (Blood Sugar)IBA
08/2009
1CreatinineIBA
02/2007
1pexelizumabIBA
02/2006
1Complement C5 (Complement 5)IBA
02/2006
1Angiotensin Receptor AntagonistsIBA
09/2004
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2004
1DiureticsIBA
09/2004
1Pharmaceutical PreparationsIBA
09/2004
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2004
1Enoxaparin (Lovenox)FDA LinkGeneric
07/2003
1Adenosine (Adenocard)FDA LinkGeneric
09/2002
1ThrombinFDA Link
08/2002
1lanoteplaseIBA
06/2002
1Drug CombinationsIBA
06/2002
1Angiotensin IIIBA
12/2001
1Atrial Natriuretic Factor (ANF)IBA
12/2001
1TNK-tissue plasminogen activatorIBA
12/2001
1Factor Xa InhibitorsIBA
09/2001
1DobutamineFDA LinkGeneric
08/2001
1AnticoagulantsIBA
08/2001
1Antithrombin IIIIBA
08/2001
1HDL CholesterolIBA
05/2001
1low density lipoprotein inhibitorIBA
05/2001
1oxidized low density lipoproteinIBA
05/2001
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2001
1Glucose (Dextrose)FDA LinkGeneric
04/2001
1Contrast MediaIBA
01/2001
1Gadolinium DTPA (Magnevist)FDA Link
01/2001
1gadophrin-2IBA
01/2001
1Acetates (Acetic Acid Esters)FDA Link
01/2001
1argatroban (MPQA)FDA Link
12/2000
1Cysteine (L-Cysteine)FDA Link
10/2000
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
10/2000
1DiamondIBA
08/2000
1Plasminogen Activators (Plasminogen Activator)IBA
07/2000
1Ticlopidine (Ticlid)FDA LinkGeneric
06/2000
1tetrachloroisophthalonitrile (Bravo)IBA
06/2000
1Adenosine Diphosphate (ADP)IBA
06/2000
1Clopidogrel (Plavix)FDA Link
06/2000
1thienopyridineIBA
06/2000
1lotrafibanIBA
06/2000
1StreptokinaseFDA Link
03/2000

Therapy/Procedure

8Therapeutics
01/2010 - 06/2000
7Thrombolytic Therapy
12/2007 - 02/2000
6Percutaneous Coronary Intervention
08/2009 - 04/2001
3Time-to-Treatment
11/2005 - 07/2001
2Treatment Delay
12/2007 - 11/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2007 - 02/2006
2Stents
10/2001 - 08/2000
1Radiofrequency Ablation
09/2004
1Length of Stay
01/2003
1Aftercare (After-Treatment)
12/2001